In particular, for leiomyosarcoma (LMS) the most common genetic abnormalities include the loss of function mutations in p53 and/or PTEN or activating mutations in the genes encoding the signaling molecules of the PI3K/AKT/mTOR pathway [11,12,13]. This evidence concerns the gene MTOR and leiomyosarcoma.